Regulatory Roundup: USP and Russia's Roszdravnadzor Sign MOU

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

Regulatory Roundup: USP and Russia's Roszdravnadzor Sign MOU

The US Pharmacopeia (USP) and Russia’s Roszdravnadzor, the federation’s regulatory healthcare agency, signed a memorandum of understanding in April 2009 to work toward protecting and improving the quality of medicines. As part of the agreement, USP announced on June 1, 2010, that it has completed a series of eight drug quality courses at Moscow’s Scientific Center for Expertise of Medical Products. Approximately 100 Russian laboratory specialists attended the workshops. 

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.